Pyridinemethanol-carboxylate esters form octahedral complexes with Zn(NO3 )2 in aqueous DMF that subsequently undergo hydrolysis at elevated temperatures to form metal-carboxylate zwitterions. In situ deprotonation of the hydroxy group leads to thermally robust, neutral MOFs. This stepwise synthesis can be controlled by temperature and is made possible by the subtle difference in reactivity of the functional groups.
This month's cover is dedicated to the golden anniversary of Singapore by the collaborating groups of Wen-Hua Zhang of the IMRE, Singapore, and T. S. Andy Hor of the NUS, Singapore, and two more groups from Monash University, Malaysia, and Soochow University, P. R. China. In the cover picture the number "50" commemorates the 50th anniversary of Singapore, the Lion City. The photo on the top-right corner shows the modern skyline of Singapore. Underneath are the structures described in this article. Read the full text of the article at 10.1002/cplu.201500134.
Morusin is a natural product that has been isolated from the bark of Morus alba, a species of mulberry tree. It belongs to the flavonoid family of chemicals, which is abundantly present in the plant world and is recognized for its wide range of biological activities. Morusin has a number of biological characteristics, including anti-inflammatory, anti-microbial, neuro-protective, and antioxidant capabilities. Morusin has exhibited anti-tumor properties in many different forms of cancer, including breast, prostate, gastric, hepatocarcinoma, glioblastoma, and pancreatic cancer. Potential of morusin as an alternative treatment method for resistant malignancies needs to be explored in animal models in order to move toward clinical trials. In the recent years several novel findings regarding the therapeutic potential of morusin have been made. This aim of this review is to provide an overview of the present understanding of morusin's beneficial effects on human health as well as provide a comprehensive and up-to-date discussion of morusin's anti-cancer properties with a special focus on in vitro and in vivo studies. This review will aid future research on the creation of polyphenolic medicines in the prenylflavone family, for the management and treatment of cancers.